PH12019501070A1 - Sustained-release dosage forms of ruxolitinib - Google Patents

Sustained-release dosage forms of ruxolitinib

Info

Publication number
PH12019501070A1
PH12019501070A1 PH12019501070A PH12019501070A PH12019501070A1 PH 12019501070 A1 PH12019501070 A1 PH 12019501070A1 PH 12019501070 A PH12019501070 A PH 12019501070A PH 12019501070 A PH12019501070 A PH 12019501070A PH 12019501070 A1 PH12019501070 A1 PH 12019501070A1
Authority
PH
Philippines
Prior art keywords
ruxolitinib
sustained
dosage forms
release dosage
useful
Prior art date
Application number
PH12019501070A
Inventor
Yong Ni
Bhavnish Parikh
Krishnaswamy Yeleswaram
Susan Erickson-Viitanen
William V Williams
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/070012 external-priority patent/WO2014078486A1/en
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of PH12019501070A1 publication Critical patent/PH12019501070A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
PH12019501070A 2012-11-15 2019-05-14 Sustained-release dosage forms of ruxolitinib PH12019501070A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261726893P 2012-11-15 2012-11-15
PCT/US2013/070012 WO2014078486A1 (en) 2012-11-15 2013-11-14 Sustained-release dosage forms of ruxolitinib
US201661769408P 2016-02-26 2016-02-26

Publications (1)

Publication Number Publication Date
PH12019501070A1 true PH12019501070A1 (en) 2020-07-06

Family

ID=71571970

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019501070A PH12019501070A1 (en) 2012-11-15 2019-05-14 Sustained-release dosage forms of ruxolitinib

Country Status (1)

Country Link
PH (1) PH12019501070A1 (en)

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
AU2018236800B2 (en) DNA-PK inhibitors
MX2013011908A (en) Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors.
IN2014DN09434A (en)
EA201690962A1 (en) COMPOSITIONS
MX345535B (en) Partially saturated tricyclic compounds and methods of making and using same.
MX2014008706A (en) Tricyclic sulfonamide compounds and methods of making and using same.
PH12015502365A1 (en) Bace1 inhibitors
MX2016003823A (en) A selective inhibitor of phosphatidylinositol 3-kinase-gamma.
EA201500112A1 (en) 3-SUBSTITUTED DERIVATIVES ESTRA-1,3,5 (10), 16-TETRAENA, METHODS OF THEIR PRODUCTION, PHARMACEUTICAL MEANS, WHICH CONTAIN THEM, AND THEIR USE FOR RECEPTION OF MEDICINES
IN2015DN01023A (en)
EA201791009A1 (en) COMPOSITIONS CONTAINING CYCLOSPORIN
WO2014035846A3 (en) Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
MX2015005732A (en) Tricyclic compounds and methods of making and using same.
GB201302343D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods for using the same
MX2019000677A (en) B-cell-mimetic cells.
PH12015500322A1 (en) Tris(hetero)arylpyrazoles and use thereof
IN2013MU03118A (en)
PH12019501070A1 (en) Sustained-release dosage forms of ruxolitinib
AR125919A2 (en) SUSTAINED-RELEASE RUXOLITINIB DOSAGE FORMS
ECSP15025357A (en) SUSTAINED RELEASE RUXOLITINIB DOSAGE FORMS
WO2014082738A8 (en) Heteroquinoline-3-carboxamides as kcnq2/3 modulators
IN2013MU03429A (en)
MD4291C1 (en) Medicinal preparation for the treatment of otitis